Publikationer pr. år
Publikationer pr. år
Publikationer pr. år
Haemato-oncologist. Responsible for treatment of malignant lymphoma and for experimental/phase I treatment of haematological malignancies at Rigshospitalet. Head of service for Hodgkin lymphoma, Mantle cell lymphoma and Castleman’s disease.
Hodgkin lymphoma; Mantle cell lymphoma; PET/CT in lymphoma; PET-response adapted lymphoma treatment; Phase 1 haematology studies;
Chairman of the EORTC lymphoma group since 2013. Co-author of the international response criteria and guidelines for the use of imaging in lymphoma. Co-author of the European society of Medical Oncology (ESMO) guidelines for Hodgkin lymphoma and ’ultra high-risk’ lymphomas.
Faculty member for the EHA Clinical Research Training in Haematology programme
Member of the scientific committee for the European Haematology Association
National principal investigator or sub-investigator for >25 solid tumour and haematology phase I trials
National principal investigator for three mantle cell lymphoma trials (one ongoing and two planned) and three Hodgkin lymphoma trials.
Site principal investigator or sub-investigator for >20 lymphoma and myeloma phase II and phase III trials
None
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review
Publikation: Bidrag til tidsskrift › Letter › peer review
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review
Publikation: Bidrag til tidsskrift › Review › peer review